Literature DB >> 24387934

Magnetic resonance imaging features of papillary breast lesions.

Ozgur Sarica1, Fatih Uluc2, Deniz Tasmali3.   

Abstract

PURPOSE: This study was aimed to assess the role of magnetic resonance imaging (MRI) in the evaluation of the papillary lesions of the breast and their morphological relationship with the mammary ducts. The potential diagnostic contributory role of ductal oriented protocols to conventional dynamic magnetic resonance examination was also explored.
MATERIALS AND METHODS: Retrospective data were collected from 46 patients who had been diagnosed with papillary breast lesions and undergone magnetic resonance examination. The presence of dilated ducts and their morphological relation with the lesion were recorded. Lesions were classified as follows: papilloma, papillomatosis and malignant papillary lesion. Statistical difference between groups was studied for each morphological and dynamic lesion characteristic.
RESULTS: Dilated ducts and characteristics of intraductal material can be identified by magnetic resonance imaging. Certain MRI findings such as a mass with crescentic peripheral fluid or focal intraductal mass on T2 weighted images may suggest the presence of an intraductal/papillary lesion. In this respect, non-fatsat T2 weighted images appear particularly useful. There was a significant difference between papilloma and papillomatosis with regard to segmental and heterogeneous contrast enhancement (p<0.05 for both comparisons). In addition, there was a significant difference between papillomas and carcinomas with regard to homogenous, heterogeneous and segmental contrast enhancement (p<0.05 for all). On the other hand, papillomatosis and carcinoma did not differ significantly in terms of any of the morphological or dynamical MR criteria compared.
CONCLUSION: Papillary lesions can be detected by MRI. Despite some overlaps in MRI findings between carcinoma, papilloma and papillomatosis, MRI may help differentiate these lesions. Major benefit of retroareolar imaging appears to arise from its ability to demonstrate ductal relation and extension of contrast enhanced regions.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Breast imaging; Ductal findings; Magnetic resonance; Papillary carcinoma; Papilloma

Mesh:

Year:  2013        PMID: 24387934     DOI: 10.1016/j.ejrad.2013.12.007

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  6 in total

1.  Contribution of Diffusion-Weighted Imaging and ADC Values to Papillary Breast Lesions.

Authors:  Wenjie Lv; Dawen Zheng; Wenbin Guan; Ping Wu
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

2.  Magnetic Resonance Imaging (MRI) Phenotypes May Provide Additional Information for Risk Stratification for Encapsulated Papillary Carcinoma of the Breast.

Authors:  Wen-Jie Tang; Yun-Shi Liang; Jing Yan; Yue Hu; Mei-Li Sun; Guo-Shun Liu; Xiao-Huan Pan; Xin-Hua Wei; Xin-Qing Jiang; Yuan Guo
Journal:  Cancer Manag Res       Date:  2020-11-17       Impact factor: 3.989

Review 3.  Magnetic resonance imaging in the evaluation of pathologic nipple discharge: indications and imaging findings.

Authors:  Naziya Samreen; Laura B Madsen; Celin Chacko; Samantha L Heller
Journal:  Br J Radiol       Date:  2021-02-05       Impact factor: 3.039

4.  Intraductal papilloma of the male breast.

Authors:  Fleur E E de Vries; Armin W Walter; Bart C Vrouenraets
Journal:  J Surg Case Rep       Date:  2016-02-09

5.  A pilot evaluation of magnetic resonance imaging characteristics seen with solid papillary carcinomas of the breast in 4 patients.

Authors:  Lina Zhang; Ling Zhuang; Chang Shi; Yanwei Miao; Weisheng Zhang; Qingwei Song; Jianyun Kang; Zhijin Lang; Xuegang Xin; Ailian Liu; Jiani Hu
Journal:  BMC Cancer       Date:  2017-08-07       Impact factor: 4.430

6.  The role of magnetic resonance imaging in detection and surgical treatment of breast intraductal papillomas.

Authors:  Na Hao; Xiaoyan Yuan; Quansheng Wang; Junyong Zhu; Yiqiong Zheng; Yanjun Zhang; Mei Liu; Liuquan Cheng; Xiru Li
Journal:  Transl Cancer Res       Date:  2019-04       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.